XML 40 R33.htm IDEA: XBRL DOCUMENT v3.24.3
Stock Options, Restricted Stock and Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity

Stock option activity is summarized as follows:

 

 

NUMBER OF
STOCK
OPTIONS

 

 

WEIGHTED-
AVERAGE
EXERCISE
PRICE

 

 

WEIGHTED-
AVERAGE
REMAINING
CONTRACTUAL
TERM (IN YEARS)

 

 

AGGREGATE
INTRINSIC
VALUE
(IN THOUSANDS)

 

Outstanding as of December 31, 2023

 

 

5,666,621

 

 

$

2.47

 

 

 

6.61

 

 

 

 

Granted

 

 

202,420

 

 

 

4.36

 

 

 

 

 

 

 

Exercised

 

 

(731,169

)

 

 

1.80

 

 

 

 

 

 

 

Cancelled, forfeited or expired

 

 

(535,917

)

 

 

3.36

 

 

 

 

 

 

 

Outstanding as of September 30, 2024

 

 

4,601,955

 

 

$

2.55

 

 

 

6.86

 

 

$

20,296

 

Exercisable as of September 30, 2024

 

 

3,519,140

 

 

$

2.40

 

 

 

6.39

 

 

$

16,049

 

Unvested as of September 30, 2024

 

 

1,082,815

 

 

$

3.04

 

 

 

8.39

 

 

$

4,247

 

Schedule of Fair Value of Stock Options Granted Was Estimated on Black-Scholes Options

The fair value of stock options granted was estimated on the grant date using the Black-Scholes option pricing model based on the following assumptions:

 

 

NINE MONTHS ENDED
SEPTEMBER 30,

 

 

 

2024

 

 

2023

 

Expected option life (years)

 

5.50 - 6.08

 

 

5.48 - 6.08

 

Risk-free interest rate

 

3.98% - 4.32%

 

 

3.50% - 4.61%

 

Expected volatility

 

99.30% - 114.68%

 

 

91.33% - 94.51%

 

Expected dividend yield

 

 

0

%

 

 

0

%

Summary of Restricted Stock Activity

Restricted stock activity is summarized as follows:

 

 

NUMBER OF
SHARES

 

 

WEIGHTED-
AVERAGE GRANT
DATE FAIR VALUE

 

Unvested at December 31, 2023

 

 

2,526,432

 

 

$

1.06

 

Granted

 

 

 

 

$

 

Vested

 

 

(1,034,207

)

 

$

0.98

 

Forfeited

 

 

(259,193

)

 

$

1.11

 

Unvested at September 30, 2024

 

 

1,233,032

 

 

$

1.12

 

 

Schedule of Stock-based Compensation Expense

Stock-based compensation expense for the three and nine months ended September 30, 2024 and 2023 was classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):

 

 

 

THREE MONTHS ENDED
SEPTEMBER 30,

 

 

NINE MONTHS ENDED
SEPTEMBER 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Research and development

 

$

646

 

 

$

270

 

 

$

2,468

 

 

$

883

 

General and administrative

 

 

538

 

 

 

416

 

 

 

1,600

 

 

 

1,269

 

Total stock-based compensation expense

 

$

1,184

 

 

$

686

 

 

$

4,068

 

 

$

2,152